Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05698212 · ClinicalTrials.gov registry record · Phase 2

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

A Phase 2 study of Endometriosis and Diagnosis, sponsored by Hera Biotech.

Recruiting
Registry status
Phase 2
Development phase
75
Enrollment target
3
Study locations

NCT05698212 is a Phase 2 study of Endometriosis and Diagnosis that is actively recruiting participants, run by Hera Biotech. The registered enrollment target is 75 participants, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05698212, a Phase 2 study of Endometriosis and Diagnosis, is actively recruiting participants, sponsored by Hera Biotech.

RECRUITING
Registry status
Phase 2
Development phase
75 participants
Enrollment target
3
Study locations

Study Summary

This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.

Conditions Studied

Endometriosis Diagnosis

Interventions

  • DIAGNOSTIC_TEST MetriDx

Study Locations (3)

Texas

  • Corpus Christi Women's Center - Corpus Christi
  • University of Texas Physician's Women's Center--Memorial City - Houston

Michigan

  • Valley OB-GYN Clinic, PC - Saginaw

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-09-14
Est. Completion 2023-04-10
Phase Phase 2

Sponsor

Hera Biotech

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05698212

The ClinicalTrials.gov registry entry for NCT05698212 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 263-participant average among 48 other Endometriosis trials with a reported enrollment target (71% lower). The listed sponsor is Hera Biotech, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 1 intervention - of which MetriDx is the first listed.

NCT05698212 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Texas, Michigan.

Frequently Asked Questions

What is clinical trial NCT05698212 about?

NCT05698212 is a clinical study titled "Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers". This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.

What is the current status of trial NCT05698212?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2022-09-14. Estimated completion is 2023-04-10.

What conditions does trial NCT05698212 study?

This clinical trial studies the following conditions: Endometriosis, Diagnosis.

What interventions are being tested in trial NCT05698212?

The interventions under investigation include: MetriDx (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05698212?

This trial is sponsored by Hera Biotech, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05698212 being conducted?

This trial has 3 study locations across Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Endometriosis

All registered trials for this condition

Diagnosis

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.